Cancer invasion proteome: Integrative preclinical and translational studies for molecular understanding and therapeutic targeting

被引:0
|
作者
Alaoui-Jamali, M. [1 ,2 ]
机构
[1] McGill Univ, Jewish Gen Hosp, Segal Canc Ctr, Dept Med, Montreal, PQ H3T 1E2, Canada
[2] McGill Univ, Jewish Gen Hosp, Segal Canc Ctr, Dept Oncol, Montreal, PQ H3T 1E2, Canada
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
113
引用
收藏
页码:S8 / S8
页数:1
相关论文
共 50 条
  • [21] Understanding and targeting cancer stem cells: therapeutic implications and challenges
    Ke Chen
    Ying-hui Huang
    Ji-long Chen
    Acta Pharmacologica Sinica, 2013, 34 : 732 - 740
  • [22] Reporting of preclinical tumor-graft cancer therapeutic studies
    Sugar, Elizabeth
    Pascoe, Adam J.
    Azad, Nilofer
    CANCER BIOLOGY & THERAPY, 2012, 13 (13) : 1262 - 1268
  • [23] Understanding and targeting cancer stem cells: therapeutic implications and challenges
    Chen, Ke
    Huang, Ying-hui
    Chen, Ji-long
    ACTA PHARMACOLOGICA SINICA, 2013, 34 (06) : 732 - 740
  • [24] The local microenvironment matters in preclinical basic and translational studies of cancer immunology and immunotherapy
    Ho, William W.
    Pittet, Mikael J.
    Fukumura, Dai
    Jain, Rakesh K.
    CANCER CELL, 2022, 40 (07) : 701 - 702
  • [25] Cancer interception by interceptor molecules: mechanistic, preclinical and human translational studies with chlorophylls
    Dashwood, Roderick H.
    GENES AND ENVIRONMENT, 2021, 43 (01)
  • [26] Cancer interception by interceptor molecules: mechanistic, preclinical and human translational studies with chlorophylls
    Roderick H. Dashwood
    Genes and Environment, 43
  • [27] Understanding and Targeting the Colon Cancer Pathogenesis: A Molecular Perspective
    Khan, Imran
    BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 58
  • [28] Novel Therapeutic Approaches Targeting Post-Translational Modifications in Lung Cancer
    Baietti, Maria Francesca
    Sewduth, Raj Nayan
    PHARMACEUTICS, 2023, 15 (01)
  • [29] Integrative clinical and preclinical studies identify FerroTerminator1 as a potent therapeutic drug for MASH
    Tao, Liang
    Yang, Xinquan
    Ge, Chaodong
    Zhang, Peng
    He, Wenjian
    Xu, Xingbo
    Li, Xin
    Chen, Wenteng
    Yu, Yingying
    Zhang, Huai
    Chen, Sui-Dan
    Pan, Xiao-Yan
    Su, Yunxing
    Xu, Chengfu
    Yu, Yongping
    Zheng, Ming-Hua
    Min, Junxia
    Wang, Fudi
    CELL METABOLISM, 2024, 36 (10)
  • [30] Molecular mechanism of pancreatic cancer—understanding proliferation, invasion, and metastasis
    André L. Mihaljevic
    Christoph W. Michalski
    Helmut Friess
    Jörg Kleeff
    Langenbeck's Archives of Surgery, 2010, 395 : 295 - 308